期刊文献+

胆固醇24S-羟化酶基因多态性与阿尔茨海默病的相关性分析 被引量:8

An intronic cholesterol 24S-hydroxylase polymorphism associated with Alzheimer disease
原文传递
导出
摘要 目的探讨胆固醇24S-羟化酶(cholesterol 24-hydroxylase,CYP46)基因第二内含子单核苷酸多态性(single nucleotide polymorphism,SNP)与阿尔茨海默病(AD)的相互关系。方法采用等位基因特异性聚合酶链反应(allele—specific PCR,A—SPCR)技术检测508例AD患者和549名健康老年人CYP46基因第二内含子基因SNP的分布,并通过比值比(OR)做疾病关联分析。结果AD组与对照组CYP46基因SNP分布差异有统计学意义(12,9%,8.1%;X^2=6.59,P=0.037),AD组携带T等位基因(C/T+T/T)频率明显高于健康对照组(91.9%,87.0%;X^2=6,58,P=0.01)。Logistic回归分析表明,C/T和T/T基因型均是AD的危险因素,调整年龄和性别的影响后,其OR值分别为:1.70(95%CI=1.10—2.63,C/T),1.69(95% CI=1.10—2.59,T/T)。结论CYP46基因的SNP与AD存在相关性,携带T等位基因可能是AD的危险因素。 Objective To evaluate the association of an intronic single nucleotide polymorphism (SNP) in cholesterol 24S-hydroxylase 0(CYP46) gene with Alzheimer's disease (AD) in Chinese Han population. Methods An intronic SNP of CYP46 gene was detected by Allele-Specific PCR (A-S PCR) technique in 508 patients with AD and 549 controls. Results The distribution of CYP46 genotypes was significantly different in AD patients as compared to the controls ( 12.9% vs 8.1% ; X^2 = 6.59, P = 0. 037). The presence of at least one of CYP46 T allele (C/T or T/T) was higher in AD patients than the controls(91.9% vs 87. 1% ; X^2 =6.58, P =0. 01 ). One-Way ANOVA showed that CYP46 genotype had no effects on the age of onset of AD. Logistic regression analysis demonstrated the age and sex-adjusted OR for the risk of AD in CYP46 C/T and in CYP46 T/T genotype were 1.70 (95% CI = 1.10-2. 63 ) and 1.69 (95% CI = 1.10-2.59) respectively. Condusion This intronic SNP in CYP46 gene is associated with AD in Chinese Han population, and the T allele might be a risk factor for AD.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2006年第1期44-47,共4页 Chinese Journal of Neurology
基金 国家"九五"攻关资助项目(96-096-05-01) 美国中华医学基金会国际合作资助项目(99-699)
关键词 阿尔茨海默病 甾类-羟化酶类 聚合酶链反应 多态性 单核苷酸 Alzheimer disease Steroid-hydroxylases Polymerase chain reaction Polymorphism, single nucleotide
  • 相关文献

参考文献16

  • 1Fassbender K, Simons M, Bergmann C, et al. Simvastatin strongly reduces Alzheimer' s disease A1542 and AβIO levels in vitro and in vivo. Proc Natl Acad Sci U S A, 2001,98:5856-5861.
  • 2Papassotiropeulos A, Lutjohann D, Bagli M, et al. Plasma 24Shydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer' s disease. Neuroreport,2000, 11:1959-1962.
  • 3Papassotiropoulos A, Streffer JR, Tsolaki M, et al. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol,2003, 60:29-35.
  • 4Wang B, Zhang C, Zheng W, et al. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese. Neurosci Lett 2004, 369: 104-107.
  • 5Borroni B, Archetti S, Agosfi C, et aL Intronic CYP46 polymorphism along with APOE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neumbiol Aging,2004, 25 : 747-751.
  • 6Combarros O, lnfante J, Llorca J, et al. Genetic association of CYP46 and risk for Alzheimer's disease. Dementia Geriatr Cogn Disord, 2004, 18: 257-260.
  • 7Desai P, DeKosky ST, Kamboh MI, et al. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer' s disease. Neurosci Lett, 2002, 328:9-12.
  • 8Chalmers KA, Culpan D, Kehoe PG, et al. APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer' s disease.Neuroreport, 2004, 15: 95-98.
  • 9Kolsch H, Lutjohann D, Ludwig M, et al. Polymorphism in the cholesterol 24S-hydroxylase geue is associated with Alzheimer's disease. Mol Psychiatry, 2002, 7 : 899-902.
  • 10Ingelsson M, Jesneck J, Irizarry MC, et al. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer' s disease. Neurosci Lett 2004, 367:228-231.

同被引文献115

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部